{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:59:02Z","timestamp":1790279942737,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03465-9","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:48:18Z","timestamp":1781038098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Solvent\u2011Free Bioerodible Ophthalmic Inserts for Mangiferin Delivery: Physicochemical Characterization and In Vivo Evaluation"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3857-8708","authenticated-orcid":false,"given":"Nam V.","family":"Dao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0368-7405","authenticated-orcid":false,"given":"Tu V.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9402-2912","authenticated-orcid":false,"given":"Anh Q.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"108","key":"3465_CR1","first-page":"68","volume":"33","author":"B Bagga","year":"2020","unstructured":"Bagga B, Kate A, Joseph J, Dave VP. Herpes simplex infection of the eye: an introduction. Commun Eye Health J. 2020;33(108):68\u201370.","journal-title":"Commun Eye Health J"},{"issue":"5","key":"3465_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","volume":"57","author":"AV Farooq","year":"2012","unstructured":"Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol. 2012;57(5):448\u201362. https:\/\/doi.org\/10.1016\/j.survophthal.2012.01.005.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"3465_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/09286586.2021.1962919","volume":"29","author":"I McCormick","year":"2022","unstructured":"McCormick I, James C, Welton NJ, Mayaud P, Turner KME, Gottlieb SL, et al. Incidence of Herpes simplex virus keratitis and other ocular disease: global review and estimates. Ophthalmic Epidemiol. 2022;29(4):353\u201362. https:\/\/doi.org\/10.1080\/09286586.2021.1962919.","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"3465_CR4","first-page":"247","volume":"112","author":"Y Shimomura","year":"2008","unstructured":"Shimomura Y. Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis. Nippon Ganka Gakkai Zasshi. 2008;112(3):247\u201364.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"9","key":"3465_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/bjo.71.9.669","volume":"71","author":"MS Wishart","year":"1987","unstructured":"Wishart MS, Darougar S, Viswalingam ND. Recurrent Herpes simplex virus ocular infection: epidemiological and clinical features. Br J Ophthalmol. 1987;71(9):669\u201372. https:\/\/doi.org\/10.1136\/bjo.71.9.669.","journal-title":"Br J Ophthalmol"},{"key":"3465_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S80475","author":"TN Azher","year":"2017","unstructured":"Azher TN, Yin X-T, Tajfirouz D, Huang AJ, Stuart PM. Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol (Auckl). 2017. https:\/\/doi.org\/10.2147\/OPTH.S80475.","journal-title":"Clin Ophthalmol (Auckl)"},{"issue":"5","key":"3465_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1128\/aac.19.5.937","volume":"19","author":"RJ Klein","year":"1981","unstructured":"Klein RJ, DeStefano E, Friedman-Kien AE, Brady E. Effect of acyclovir on latent Herpes simplex virus infections in trigeminal ganglia of mice. Antimicrob Agents Chemother. 1981;19(5):937\u20139. https:\/\/doi.org\/10.1128\/aac.19.5.937.","journal-title":"Antimicrob Agents Chemother"},{"key":"3465_CR8","unstructured":"Pottage JC Jr., Kessler HA. Herpes simplex virus resistance to acyclovir: clinical relevance. Infect Agents Dis. 1995;4(3):115\u201324."},{"key":"3465_CR9","volume-title":"Advanced Drug Formulation Design to Optimize Therapeutic Outcomes","author":"IRO Williams","year":"2008","unstructured":"Williams IRO, Taft DR, T MJ. Advanced Drug Formulation Design to Optimize Therapeutic Outcomes. New York, USA: Taylor & Francis Group; 2008."},{"issue":"3","key":"3465_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0166-0934(92)90052-f","volume":"36","author":"CR Brandt","year":"1992","unstructured":"Brandt CR, Coakley LM, Grau DR. A murine model of herpes simplex virus-induced ocular disease for antiviral drug testing. J Virol Methods. 1992;36(3):209\u201322. https:\/\/doi.org\/10.1016\/0166-0934(92)90052-f.","journal-title":"J Virol Methods"},{"issue":"1","key":"3465_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1515\/jcim-2019-0250","volume":"18","author":"S Mittal","year":"2020","unstructured":"Mittal S, Iqubal MK, Iqbal B, Gupta MM, Ali J, Baboota S. A pervasive scientific overview on mangiferin in the prevention and treatment of various diseases with preclinical and clinical updates. J Complement Integr Med. 2020;18(1):9\u201321. https:\/\/doi.org\/10.1515\/jcim-2019-0250.","journal-title":"J Complement Integr Med"},{"issue":"6","key":"3465_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s0944-7113(00)80068-9","volume":"6","author":"C Yoosook","year":"2000","unstructured":"Yoosook C, Bunyapraphatsara N, Boonyakiat Y, Kantasuk C. Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine. 2000;6(6):411\u20139. https:\/\/doi.org\/10.1016\/s0944-7113(00)80068-9.","journal-title":"Phytomedicine"},{"issue":"4","key":"3465_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115304","volume":"28","author":"DZ Rechenchoski","year":"2020","unstructured":"Rechenchoski DZ, Agostinho KF, Faccin-Galhardi LC, Lonni AASG, da Silva JVH, de Andrade FG, et al. Mangiferin: a promising natural xanthone from Mangifera indica for the control of Acyclovir\u2013resistant herpes simplex virus 1 infection. Bioorg Med Chem. 2020;28(4):115304. https:\/\/doi.org\/10.1016\/j.bmc.2020.115304.","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"3465_CR14","first-page":"160","volume":"103","author":"MS Zheng","year":"1990","unstructured":"Zheng MS, Lu ZY. Antiviral effect of mangiferin and isomangiferin on herpes simplex virus. Chin Med J (Engl). 1990;103(2):160\u20135.","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"3465_CR15","first-page":"452","volume":"14","author":"XM Zhu","year":"1993","unstructured":"Zhu XM, Song JX, Huang ZZ, Wu YM, Yu MJ. Antiviral activity of mangiferin against herpes simplex virus type 2 in vitro. Zhongguo Yao Li Xue Bao. 1993;14(5):452\u20134.","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"3465_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4763015","volume":"2019","author":"RA Reddeman","year":"2019","unstructured":"Reddeman RA, Gl\u00e1vits R, Endres JR, Clewell AE, Hirka G, V\u00e9rtesi A, et al. A toxicological evaluation of mango leaf extract (Mangifera indica) containing 60% mangiferin. J Toxicol. 2019;2019:4763015. https:\/\/doi.org\/10.1155\/2019\/4763015.","journal-title":"J Toxicol"},{"key":"3465_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.fitote.2013.10.016","volume":"93","author":"H Ma","year":"2014","unstructured":"Ma H, Chen H, Sun L, Tong L, Zhang T. Improving permeability and oral absorption of mangiferin by phospholipid complexation. Fitoterapia. 2014;93:54\u201361. https:\/\/doi.org\/10.1016\/j.fitote.2013.10.016.","journal-title":"Fitoterapia"},{"issue":"3","key":"3465_CR18","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-021-01977-0","volume":"22","author":"OL Lanier","year":"2021","unstructured":"Lanier OL, Manfre MG, Bailey C, Liu Z, Sparks Z, Kulkarni S, et al. Review of approaches for increasing ophthalmic bioavailability for eye drop formulations. AAPS PharmSciTech. 2021;22(3):107. https:\/\/doi.org\/10.1208\/s12249-021-01977-0.","journal-title":"AAPS PharmSciTech"},{"key":"3465_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061646","author":"CP Santana","year":"2023","unstructured":"Santana CP, Matter BA, Patil MA, Silva-Cunha A, Kompella UB. Corneal permeability and uptake of twenty-five drugs: species comparison and quantitative structure-permeability relationships. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15061646.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3465_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/15569520903471640","volume":"29","author":"S-A Cho","year":"2010","unstructured":"Cho S-A, Han J-H, An S, Lee KH, Park J-H, Kim HK, et al. Comparative study of the ocular irritation potential of various alkyl polyglucoside surfactants. Cutan Ocul Toxicol. 2010;29(1):50\u20136. https:\/\/doi.org\/10.3109\/15569520903471640.","journal-title":"Cutan Ocul Toxicol"},{"issue":"10","key":"3465_CR21","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1002\/jps.23251","volume":"101","author":"R Liu","year":"2012","unstructured":"Liu R, Liu Z, Zhang C, Zhang B. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. J Pharm Sci. 2012;101(10):3833\u201344. https:\/\/doi.org\/10.1002\/jps.23251.","journal-title":"J Pharm Sci"},{"issue":"8","key":"3465_CR22","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1002\/jps.22540","volume":"100","author":"R Liu","year":"2011","unstructured":"Liu R, Liu Z, Zhang C, Zhang B. Gelucire44\/14 as a novel absorption enhancer for drugs with different hydrophilicities: in vitro and in vivo improvement on transcorneal permeation. J Pharm Sci. 2011;100(8):3186\u201395. https:\/\/doi.org\/10.1002\/jps.22540.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3465_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0169-409X(95)00014-X","volume":"16","author":"MF Saettone","year":"1995","unstructured":"Saettone MF, Salminen L. Ocular inserts for topical delivery. Adv Drug Deliv Rev. 1995;16(1):95\u2013106. https:\/\/doi.org\/10.1016\/0169-409X(95)00014-X.","journal-title":"Adv Drug Deliv Rev"},{"key":"3465_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103333","volume":"71","author":"SA Khan","year":"2022","unstructured":"Khan SA, Ma X, Jermain SV, Ali H, Khalil IA, El Fouly M, et al. Sustained release biocompatible ocular insert using hot melt extrusion technology: fabrication and in-vivo evaluation. J Drug Deliv Sci Technol. 2022;71:103333. https:\/\/doi.org\/10.1016\/j.jddst.2022.103333.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3465_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejpb.2022.10.023","volume":"181","author":"M Mariz","year":"2022","unstructured":"Mariz M, Murta J, Gil MH, Ferreira P. An ocular insert with zero-order extended delivery: release kinetics and mathematical models. Eur J Pharm Biopharm. 2022;181:79\u201387. https:\/\/doi.org\/10.1016\/j.ejpb.2022.10.023.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"3465_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/0110-5558.72419","volume":"1","author":"A Kumari","year":"2010","unstructured":"Kumari A, Sharma PK, Garg VK, Garg G. Ocular inserts - advancement in therapy of eye diseases. J Adv Pharm Technol Res. 2010;1(3):291\u20136. https:\/\/doi.org\/10.4103\/0110-5558.72419.","journal-title":"J Adv Pharm Technol Res"},{"issue":"10","key":"3465_CR27","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1021\/acs.molpharmaceut.5c00808","volume":"22","author":"A Das","year":"2025","unstructured":"Das A, Lekurwale S, Mahajan S, Banerjee SK, Banerjee S. Infill-modulated, bioerodible, and biocompatible ocular inserts for tunable acyclovir release via direct powder extrusion 3D printing. Mol Pharm. 2025;22(10):6092\u2013107. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00808.","journal-title":"Mol Pharm"},{"key":"3465_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124699","volume":"665","author":"S Taghe","year":"2024","unstructured":"Taghe S, Mirzaeei S, Pakdaman N, Kazemi A, Nokhodchi A. Macrolide-loaded nanofibrous inserts with polycaprolactone and cellulose acetate base for sustained ocular delivery: pharmacokinetic study in rabbit\u2019s eye. Int J Pharm. 2024;665:124699. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124699.","journal-title":"Int J Pharm"},{"key":"3465_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/B978-0-08-099417-8.00006-7","volume-title":"Design of Experiments for Engineers and Scientists","author":"J Antony","year":"2014","unstructured":"Antony J. 6 - Full Factorial Designs. In: Antony J, editor. Design of Experiments for Engineers and Scientists. 2nd ed. Oxford: Elsevier; 2014. p. 63\u201385.","edition":"2"},{"issue":"1","key":"3465_CR30","doi-asserted-by":"publisher","DOI":"10.1208\/pt040107","volume":"4","author":"M Siewert","year":"2003","unstructured":"Siewert M, Dressman J, Brown CK, Shah VP. FIP\/AAPS guidelines to dissolution\/in vitro release testing of novel\/special dosage forms. AAPS PharmSciTech. 2003;4(1):E7. https:\/\/doi.org\/10.1208\/pt040107.","journal-title":"AAPS PharmSciTech"},{"key":"3465_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.59882\/1859-364X\/161","volume":"16","author":"N Dao","year":"2024","unstructured":"Dao N, Tran Q, Le T, Nguyen D, Vo A. Developing a quantitative method of mangiferin in rabbit lacrimal fluid as a tool for investigating pre-cornea drug residence. J Pharm Res Drug Inf. 2024;16:10\u201321. https:\/\/doi.org\/10.59882\/1859-364X\/161.","journal-title":"J Pharm Res Drug Inf"},{"key":"3465_CR32","unstructured":"Food and Drug Administration USA. Bioanalytical method validation guidance for industry. US Department of Health and Human Services; 2018. p. 1\u201341."},{"key":"3465_CR33","unstructured":"European Medicines Agency, ICH guideline M10 on bioanalytical method validation and study sample analysis; 2022. p. 1\u201345."},{"issue":"1","key":"3465_CR34","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/237501","volume":"2011","author":"AH Ahad","year":"2011","unstructured":"Ahad AH, Sreeramulu J, Padmaja BS, Reddy MN, Prakash PG. Preparation of fluconazole \u03b2-cyclodextrin complex ocuserts: in vitro and in vivo evaluation. Int Sch Res Not. 2011;2011(1):237501. https:\/\/doi.org\/10.5402\/2011\/237501.","journal-title":"Int Sch Res Not"},{"key":"3465_CR35","doi-asserted-by":"publisher","unstructured":"OECD. Test no. 405: acute eye irritation\/corrosion. OECD guidelines for the testing of chemicals, section 4. OECD Publishing; 2023. https:\/\/doi.org\/10.1787\/9789264185333-en","DOI":"10.1787\/9789264185333-en"},{"issue":"3","key":"3465_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263\u201371. https:\/\/doi.org\/10.1208\/s12248-010-9185-1.","journal-title":"AAPS J"},{"key":"3465_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123183","volume":"642","author":"V Naageshwaran","year":"2023","unstructured":"Naageshwaran V, Bigonne H, Gum G, Malla S, Del Sol C, Bon C, et al. Topical pharmacokinetics of brinzolamide suspensions in rabbits and variability analysis for sample size and design considerations. Int J Pharm. 2023;642:123183. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123183.","journal-title":"Int J Pharm"},{"issue":"22","key":"3465_CR38","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1021\/acs.jafc.5b01657","volume":"63","author":"T Beelders","year":"2015","unstructured":"Beelders T, de Beer D, Joubert E. Thermal degradation kinetics modeling of benzophenones and xanthones during high-temperature oxidation of Cyclopia genistoides (L.) Vent. plant material. J Agric Food Chem. 2015;63(22):5518\u201327. https:\/\/doi.org\/10.1021\/acs.jafc.5b01657.","journal-title":"J Agric Food Chem"},{"key":"3465_CR39","unstructured":"Sartorius Stedim Data Analytics AB. Modde 13 user guide; 2021."},{"key":"3465_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ani9100754","author":"RC Hubrecht","year":"2019","unstructured":"Hubrecht RC, Carter E. The 3Rs and humane experimental technique: implementing change. Animals (Basel). 2019. https:\/\/doi.org\/10.3390\/ani9100754.","journal-title":"Animals (Basel)"},{"key":"3465_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102979","volume":"68","author":"AS Pokkalath","year":"2022","unstructured":"Pokkalath AS, Sawant A, Sawarkar SP. Herbal medicine for ocular diseases: an age old therapy and its future perspective. J Drug Deliv Sci Technol. 2022;68:102979. https:\/\/doi.org\/10.1016\/j.jddst.2021.102979.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3465_CR42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.carbpol.2013.09.017","volume":"101","author":"AL Sarode","year":"2014","unstructured":"Sarode AL, Obara S, Tanno FK, Sandhu H, Iyer R, Shah N. Stability assessment of hypromellose acetate succinate (HPMCAS) NF for application in hot melt extrusion (HME). Carbohydr Polym. 2014;101:146\u201353. https:\/\/doi.org\/10.1016\/j.carbpol.2013.09.017.","journal-title":"Carbohydr Polym"},{"issue":"7","key":"3465_CR43","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1208\/s12249-023-02645-1","volume":"24","author":"M Choudhari","year":"2023","unstructured":"Choudhari M, Damle S, Saha RN, Dubey SK, Singhvi G. Emerging applications of Hydroxypropyl Methylcellulose Acetate Succinate: different aspects in drug delivery and its commercial potential. AAPS PharmSciTech. 2023;24(7):188. https:\/\/doi.org\/10.1208\/s12249-023-02645-1.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"3465_CR44","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1021\/acs.molpharmaceut.9b00301","volume":"16","author":"Y Ishizuka","year":"2019","unstructured":"Ishizuka Y, Ueda K, Okada H, Takeda J, Karashima M, Yazawa K, et al. Effect of drug-polymer interactions through Hypromellose Acetate Succinate substituents on the physical stability on solid dispersions studied by Fourier-Transform Infrared and Solid-State Nuclear Magnetic Resonance. Mol Pharm. 2019;16(6):2785\u201394. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00301.","journal-title":"Mol Pharm"},{"issue":"12","key":"3465_CR45","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1358\/dot.2007.43.12.1162080","volume":"43","author":"GN Foulks","year":"2007","unstructured":"Foulks GN. Clinical evaluation of the efficacy of PEG\/PG lubricant eye drops with gelling agent (HP-Guar) for the relief of the signs and symptoms of dry eye disease: a review. Drugs Today (Barc). 2007;43(12):887\u201396. https:\/\/doi.org\/10.1358\/dot.2007.43.12.1162080.","journal-title":"Drugs Today (Barc)"},{"key":"3465_CR46","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e318268610a","author":"E Sakai","year":"2012","unstructured":"Sakai E, Shiraishi A, Yamaguchi M, Ohta K, Ohashi Y. Blepharo-tensiometer: new eyelid pressure measurement system using tactile pressure sensor. Eye Contact Lens. 2012. https:\/\/doi.org\/10.1097\/ICL.0b013e318268610a.","journal-title":"Eye Contact Lens"},{"key":"3465_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.fpsl.2023.101086","volume":"37","author":"Y Jeong","year":"2023","unstructured":"Jeong Y, Sadeghi K, Seo J. Effects of molecular weight of polyethylene glycol on the moisture-absorption capacity and morphology of the channeling structure in desiccant composite. Food Packag Shelf Life. 2023;37:101086. https:\/\/doi.org\/10.1016\/j.fpsl.2023.101086.","journal-title":"Food Packag Shelf Life"},{"issue":"11","key":"3465_CR48","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.2600651123","volume":"65","author":"A Longwell","year":"1976","unstructured":"Longwell A, Birss S, Keller N, Moore D. Effect of topically applied pilocarpine on tear film pH. J Pharm Sci. 1976;65(11):1654\u20137. https:\/\/doi.org\/10.1002\/jps.2600651123.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3465_CR49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/archopht.1981.03930010303017","volume":"99","author":"MB Abelson","year":"1981","unstructured":"Abelson MB, Udell IJ, Weston JH. Normal human tear pH by direct measurement. Arch Ophthalmol. 1981;99(2):301. https:\/\/doi.org\/10.1001\/archopht.1981.03930010303017.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"3465_CR50","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/bjo.68.8.549","volume":"68","author":"WH Coles","year":"1984","unstructured":"Coles WH, Jaros PA. Dynamics of ocular surface pH. Br J Ophthalmol. 1984;68(8):549\u201352. https:\/\/doi.org\/10.1136\/bjo.68.8.549.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"3465_CR51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/2230-973x.100040","volume":"2","author":"G Khurana","year":"2012","unstructured":"Khurana G, Arora S, Pawar PK. Ocular insert for sustained delivery of gatifloxacin sesquihydrate: preparation and evaluations. Int J Pharm Investig. 2012;2(2):70\u20137. https:\/\/doi.org\/10.4103\/2230-973x.100040.","journal-title":"Int J Pharm Investig"},{"issue":"12","key":"3465_CR52","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.xphs.2017.07.017","volume":"106","author":"SP Balguri","year":"2017","unstructured":"Balguri SP, Adelli GR, Tatke A, Janga KY, Bhagav P, Majumdar S. Melt-cast noninvasive ocular inserts for posterior segment drug delivery. J Pharm Sci. 2017;106(12):3515\u201323. https:\/\/doi.org\/10.1016\/j.xphs.2017.07.017.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3465_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/10837450.2010.502178","volume":"17","author":"UL Patel","year":"2012","unstructured":"Patel UL, Chotai NP, Nagda CD. Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: in vitro and in vivo evaluation. Pharm Dev Technol. 2012;17(1):15\u201322. https:\/\/doi.org\/10.3109\/10837450.2010.502178.","journal-title":"Pharm Dev Technol"},{"key":"3465_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejpb.2020.09.010","volume":"157","author":"Y Wei","year":"2020","unstructured":"Wei Y, Hu Y, Shen X, Zhang X, Guan J, Mao S. Design of circular-ring film embedded contact lens for improved compatibility and sustained ocular drug delivery. Eur J Pharm Biopharm. 2020;157:28\u201337. https:\/\/doi.org\/10.1016\/j.ejpb.2020.09.010.","journal-title":"Eur J Pharm Biopharm"},{"key":"3465_CR55","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jconrel.2015.09.052","volume":"219","author":"J Shen","year":"2015","unstructured":"Shen J, Burgess DJ. In vitro-in vivo correlation for complex non-oral drug products: where do we stand? J Control Release. 2015;219:644\u201351. https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.052.","journal-title":"J Control Release"},{"issue":"9","key":"3465_CR56","first-page":"901","volume":"8","author":"N Efron","year":"1989","unstructured":"Efron N, Young G, Brennan NA. Ocular surface temperature. Curr Eye Res. 1989;8(9):901\u20136.","journal-title":"Curr Eye Res"},{"issue":"4","key":"3465_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040452","volume":"13","author":"E Toropainen","year":"2021","unstructured":"Toropainen E, Fraser-Miller SJ, Novakovic D, Del Amo EM, Vellonen K-S, Ruponen M, et al. Biopharmaceutics of topical ophthalmic suspensions: importance of viscosity and particle size in ocular absorption of indomethacin. Pharmaceutics. 2021;13(4):452. https:\/\/doi.org\/10.3390\/pharmaceutics13040452.","journal-title":"Pharmaceutics"},{"issue":"11","key":"3465_CR58","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1021\/acs.molpharmaceut.3c00586","volume":"20","author":"P Bapat","year":"2023","unstructured":"Bapat P, Paul S, Thakral NK, Tseng Y-C, Taylor LS. Does media choice matter when evaluating the performance of hydroxypropyl methylcellulose acetate succinate-based amorphous solid dispersions? Mol Pharm. 2023;20(11):5714\u201327. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00586.","journal-title":"Mol Pharm"},{"issue":"2","key":"3465_CR59","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/aic.10329","volume":"51","author":"DA Nguyen","year":"2005","unstructured":"Nguyen DA, Fogler HS. Facilitated diffusion in the dissolution of carboxylic polymers. AIChE J. 2005;51(2):415\u201325. https:\/\/doi.org\/10.1002\/aic.10329.","journal-title":"AIChE J"},{"issue":"4","key":"3465_CR60","doi-asserted-by":"publisher","first-page":"E553","DOI":"10.1208\/pt060470","volume":"6","author":"SS D\u2019Souza","year":"2005","unstructured":"D\u2019Souza SS, Faraj JA, DeLuca PP. A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. AAPS PharmSciTech. 2005;6(4):E553-64. https:\/\/doi.org\/10.1208\/pt060470.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"3465_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0142-9612(80)90060-5","volume":"1","author":"J Heller","year":"1980","unstructured":"Heller J. Controlled release of biologically active compounds from bioerodible polymers. Biomaterials. 1980;1(1):51\u20137. https:\/\/doi.org\/10.1016\/0142-9612(80)90060-5.","journal-title":"Biomaterials"},{"issue":"7","key":"3465_CR62","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/jps.2600620712","volume":"62","author":"SS Chrai","year":"1973","unstructured":"Chrai SS, Patton TF, Mehta A, Robinson JR. Lacrimal and instilled fluid dynamics in rabbit eyes. J Pharm Sci. 1973;62(7):1112\u201321. https:\/\/doi.org\/10.1002\/jps.2600620712.","journal-title":"J Pharm Sci"},{"key":"3465_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119761","volume":"588","author":"A Vo","year":"2020","unstructured":"Vo A, Feng X, Patel D, Mohammad A, Patel M, Zheng J, et al. In vitro physicochemical characterization and dissolution of brinzolamide ophthalmic suspensions with similar composition. Int J Pharm. 2020b;588:119761. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119761.","journal-title":"Int J Pharm"},{"issue":"1","key":"3465_CR64","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijpharm.2006.01.030","volume":"313","author":"C Galli","year":"2006","unstructured":"Galli C. Experimental determination of the diffusion boundary layer width of micron and submicron particles. Int J Pharm. 2006;313(1):114\u201322. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.01.030.","journal-title":"Int J Pharm"},{"issue":"1","key":"3465_CR65","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0939-6411(97)00168-9","volume":"46","author":"P Chetoni","year":"1998","unstructured":"Chetoni P, Di Colo G, Grandi M, Morelli M, Saettone MF, Darougar S. Silicone rubber\/hydrogel composite ophthalmic inserts: preparation and preliminary in vitro\/in vivo evaluation. Eur J Pharm Biopharm. 1998;46(1):125\u201332. https:\/\/doi.org\/10.1016\/S0939-6411(97)00168-9.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3465_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1590\/s0036-46652010000100001","volume":"52","author":"G Mendes","year":"2010","unstructured":"Mendes G, Soares AR, Martins FO, Albuquerque MC, Costa SS, Yoneshigue-Valentin Y, et al. Antiviral activity of the green marine alga Ulva fasciata on the replication of human metapneumovirus. Rev Inst Med Trop Sao Paulo. 2010;52(1):3\u201310. https:\/\/doi.org\/10.1590\/s0036-46652010000100001.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"3","key":"3465_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijantimicag.2004.02.022","volume":"24","author":"W Zhu","year":"2004","unstructured":"Zhu W, Chiu LCM, Ooi VEC, Chan PKS, Ang PO. Antiviral property and mode of action of a sulphated polysaccharide from Sargassum patens against herpes simplex virus type 2. Int J Antimicrob Agents. 2004;24(3):279\u201383. https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.02.022.","journal-title":"Int J Antimicrob Agents"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03465-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03465-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03465-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:04:43Z","timestamp":1790276683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03465-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":67,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["3465"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03465-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Anh Q. Vo reports financial support was provided by Vietnam National Foundation for Science and Technology Development. Nam V. Dao reports financial support was provided by Vingroup Innovation Foundation. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"230"}}